Mamadou Barry

Also affiliated with Massachusetts General Hospital, University of Kansas Medical Center, Case Western Reserve University

MedicineAgricultural and Biological SciencesMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy”.

SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy

medRxiv(2023)10.1101/2023.06.23.23288598

N/A

0.269DataRank · unranked

5 citations

Julie Boucau, Rockib Uddin, Caitlin Marino, May Y. Liew, Mamadou Barry +17 more

SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency

medRxiv(2023)10.1101/2023.07.31.23293441

N/A

0DataRank · unranked

11 citations

Manish C. Choudhary, James Regan, Julie Boucau, Anusha Nathan, Tessa Speidel +28 more

SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency

Science Translational Medicine(2024)10.1126/scitranslmed.adk1599

N/A

0DataRank · unranked

98 citations

Manish C. Choudhary, James Regan, Julie Boucau, Anusha Nathan, Tessa Speidel +28 more

Emerging SARS-CoV-2 Resistance After Antiviral Treatment

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.35431

N/A

0DataRank · unranked

45 citations

Manish C. Choudhary, Rinki Deo, Fizah Yousuf, A. Gomez, Gregory E. Edelstein +23 more

Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.13.613000

N/A

0DataRank · unranked

2 citations

Ruy M. Ribeiro, Gregory E. Edelstein, Julie Boucau, Rockib Uddin, Caitlin Marino +20 more

Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patients

Research Square(2024)10.21203/rs.3.rs-5487774/v1

N/A

0DataRank · unranked

0 citations

Brooke M. Leeman, Patricia J. Botros, Joanna Folta, Dhiman Shahid, Anya I. Rocque +27 more

Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance

Journal of Virology(2025)10.1128/jvi.01623-24

N/A

0DataRank · unranked

18 citations

Ruy M. Ribeiro, Gregory E. Edelstein, Julie Boucau, Rockib Uddin, Caitlin Marino +20 more

Recorded Lectures as Supplementary Learning Resources in Clinical Training: An Evaluation Study

Interdisciplinary Research in Medical Sciences Specialty(2025)10.51847/hwm2uhcpjg

N/A

0DataRank · unranked

2 citations

Mamadou Barry, Ibrahima Camara, Hamidou Diallo

Virologic characteristics of SARS-CoV-2 infection across evolving Omicron subvariants

JCI Insight(2025)10.1172/jci.insight.192228

N/A

0DataRank · unranked

1 citations

Owen T. Glover, Caitlin Marino, Gregory E. Edelstein, Manish C. Choudhary, Yijia Li +17 more

SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy

Annals of Internal Medicine(2023)10.7326/m23-1756

N/A

0DataRank · unranked

73 citations

Julie Boucau, Rockib Uddin, Caitlin Marino, May Y. Liew, Mamadou Barry +17 more

Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected Patients

Vaccines(2025)10.3390/vaccines13090949

N/A

0DataRank · unranked

0 citations

Brooke M. Leeman, Patricia J. Botros, Joanna Folta, Dhiman Shahid, Anya I. Rocque +27 more